NCT00023166终止1 期
Phase I Study of PEG-Paclitaxel In Patients With Advanced Solid Tumors and Lymphomas
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 终止
研究概览
简要总结
Studies of PEG-paclitaxel have been terminated
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
招募中
不适用
Phase 2 study of paclitaxel plus anti-EGFR as a second-line therapy for gastric and gastroesophageal junction adenocarcinomasNeoplasmsKCT0004314ational Cancer Center44
已完成
2 期
Phase II pilot study of nab-paclitaxel in patients with metastatic or unresectable urothelial cancer previously treated with cisplatin-based chemotherapy.urothelial cancerJPRN-UMIN000015260Department of Urology, Saitama Medical Center, Saitama Medical University5
已完成
2 期
A Phase II Study of Paclitaxel+S-1 for previously treated Non-Small Cell Lung CancerAdvanced or relapsed Non-Small Cell Lung CancerJPRN-UMIN000003719Osaka Medical Center for Cancer and Cardiovascular Diseases50
终止
不适用
A phase III clinical study to compare paclitaxel (Genexol®-PM) in combination with standard therapy (gemcitabine/cisplatin) and standard therapy alone (gemcitabine/cisplatin) in patients with advanced biliary tractNeoplasmsKCT0003726Asan Medical Center220
招募中
不适用
Paclitaxel in patients with GIST with low P-glycoprotein expression after failure of at least imatinib and sunitinib, and regorafenib.NeoplasmsKCT0003895Asan Medical Center40